New research published on preprint server bioRxiv* S2-specific antibody response suggests that it is important for recovery from mild to severe COVID-19 infection. Patients with a...
Set in the context of today’s COVID-19 crisis, the series and companion books explore lessons learned from previous pandemics and reveal how the public health revolution...
A recent amazing feat by U.S. researchers has revealed that recombination is not just widespread in evolutionary history like SARS. Coronavirus, But it can also enhance...
An ANTICOV clinical trial conducted in 13 African countries recruited participants to test a new drug combination, nitazoxanide + ciclesonide, to treat patients with mild to...
The rapid spread of Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has infected more than 111 million people worldwide, resulting in a COVID-19 pandemic. Many scale...
According to a study published in Nature Physics, certain types of bacteria transform to adapt to long-term exposure to antibiotics. According to this study, bacteria tend...
Recent Comments